موافقات الدواء

Melphalan Hydrochloride TBM is intended for the following indications:
·Melphalan at conventional intravenous dose, is indicated in the treatment of multiple myeloma and advanced ovarian cancer.
·Melphalan, at high intravenous dosage, is indicated, with or without haematopoietic stem cell transplantation, for the treatment of multiple myeloma and childhood neuroblastoma.
·Melphalan, administered by regional arterial perfusion, is indicated in the treatment of localised malignant melanoma of the extremities and localised soft tissue sarcoma of the extremities.